Question 38693 — pharmacy and medications

Summary

Ms. Catherine Fabre draws the attention of the Minister of Solidarity and Health to the access of hospitalized patients to innovative medicines. The social security financing law for 2004 established the “extra list”, which allows 100% coverage by health insurance of certain innovative medical specialties, in addition to hospitalization rates. However, based on a report from the Institut Montaigne “Innovative medicines: prevention for better cure” published in September 2019, access to these innovative therapeutic specialties experiences disparities depending on the budgetary capacities of health establishments, which does not make it possible to give patients the same chances of access to innovative treatments. An experiment on the financing of these new health organizations has been underway since April 2018, and in particular makes it possible to derogate from numerous common law financing rules applicable in health establishments. Thus, it wishes to know whether the above-mentioned experiment takes into account the disparities in access to innovative medicines and, if so, what solutions are envisaged to allow reimbursement of these medicines to the greatest number of people, regardless of the budgetary capacities specific to each health establishment.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.